HUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average - Here's What Happened

Key Points

• HUTCHMED crossed below its 200-day moving average on Thursday, trading as low as GBX 201 versus the 200-day MA of GBX 217.39, on a volume of 53,847 shares.
• The shares show a market cap of £1.77 billion and a low PE of 3.90, but the company has a high debt-to-equity ratio of 7.91 alongside strong liquidity (current ratio 4.96, quick ratio 2.97).
• HUTCHMED is a China-focused novel drug discovery company with three approved oncology medicines (one also marketed in the U.S.) and is listed on Nasdaq, HKEX and the London AIM market.

HUTCHMED (China) Limited (LON:HCM - ) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 217.39 and traded as low as GBX 201. HUTCHMED shares last traded at GBX 201, with a volume of 53,847 shares.

HUTCHMED Trading Up 2.7%

The stock's fifty day simple moving average is GBX 214.38 and its 200-day simple moving average is GBX 217.39. The firm has a market cap of £1.77 billion, a PE ratio of 3.90 and a beta of 0.45. The company has a debt-to-equity ratio of 7.91, a current ratio of 4.96 and a quick ratio of 2.97.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.